Factors associated with depression during the perimenopausal transition.

Womens Health Issues

Monash Alfred Psychiatry Research Centre, The Alfred and Monash University, Melbourne, Victoria, Australia.

Published: November 2013

Background: This paper examines the factors associated with depressive symptoms during the perimenopausal transition, to increase the understanding about the etiology of perimenopausal depression.

Method: Seventy-six peri- and early postmenopausal women with or without current depressive symptoms were recruited (mean, 49.5 years; standard deviation, 4.3). Participants completed a series of questionnaires relating to depression (Beck Depression Inventory-II), perimenopausal symptoms (Greene Climacteric Scale), social support, life events, history of mood disorders, exercise regime, and questions regarding lifestyle and well-being.

Findings: Univariate relationships between predictors and depression scores were assessed. All significant variables at this level (history of depression, history of premenstrual syndrome, recent negative life events, aerobic exercise, social support, and somatic symptoms) were then analyzed via multiple regression. The presence of recent negative life events, a history of depression, and severity of somatic symptoms of perimenopause were all found to predict unique variance in depression scores. There was also a trend toward a protective role of aerobic exercise.

Conclusions: This study confirmed the role of negative life events, previous depression history, and somatic complaints in the development of depressive symptoms during perimenopause. Further exploration of this relationship is warranted.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.whi.2013.07.001DOI Listing

Publication Analysis

Top Keywords

life events
16
depressive symptoms
12
negative life
12
factors associated
8
depression
8
perimenopausal transition
8
social support
8
events history
8
depression scores
8
history depression
8

Similar Publications

Tumor necrosis factor receptor-associated factor 1 (TRAF1) is a crucial signaling adaptor involved in multiple cellular events. However, its role in regulating osteoclastogenesis and energy metabolism remains unclear. Here, we report that TRAF1 promotes osteoclastogenesis and oxidative phosphorylation (OXPHOS).

View Article and Find Full Text PDF

Encorafenib + cetuximab (EC) is approved for previously treated BRAF V600E-mutant metastatic colorectal cancer (mCRC) based on the BEACON phase 3 study. Historically, first-line treatment of BRAF V600E-mutant mCRC with chemotherapy regimens has had limited efficacy. The phase 3 BREAKWATER study investigated EC+mFOLFOX6 versus standard of care (SOC) in patients with previously untreated BRAF V600E mCRC.

View Article and Find Full Text PDF

Retirement has been associated with cognitive decline beyond normal age-related decline. However, there are many individual differences in retirement that can influence cognition. Subclinical depressive symptoms are common in late life and are associated with general memory decline and a bias towards remembering negative events (i.

View Article and Find Full Text PDF

Objective: Frailty has become an increasingly recognized perioperative risk stratification tool. While frailty has been strongly correlated with worsening surgical outcomes, the individual determinants of frailty have rarely been investigated in the setting of aortic disease. The aim of this study was to examine the determinants of an 11-factor modified frailty index (mFI-11) on mortality and postoperative complications in patients undergoing endovascular aortic aneurysm repair (EVAR).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!